Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"
topic_facet:"Research Support, Non-U.S. Gov't"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Journal+of+clinical+oncology+%3A+official+journal+of+the+American+Society+of+Clinical+Oncology%22&filter%5B%5D=topic_facet%3A%22Research+Support%2C+Non-U.S.+Gov%27t%22&lookfor=%22Dexamethasone%22&type=Subject
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Journal+of+clinical+oncology+%3A+official+journal+of+the+American+Society+of+Clinical+Oncology%22&filter%5B%5D=topic_facet%3A%22Research+Support%2C+Non-U.S.+Gov%27t%22&lookfor=%22Dexamethasone%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22Journal+of+clinical+oncology+%3A+official+journal+of+the+American+Society+of+Clinical+Oncology%22&filter%5B%5D=topic_facet%3A%22Research+Support%2C+Non-U.S.+Gov%27t%22&lookfor=%22Dexamethasone%22&type=Subject
PubPharm (130)
1
Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2023
von
Kaiser, M.
|
Hall, A.
|
Walker, K.
| +17
Wird geladen...
2
Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia : A Prospectively Randomized Trial of the European Consortium for Waldenström's Macroglobulinemia
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2023
von
Buske, C.
|
Dimopoulos, M.
|
Grunenberg, A.
| +22
CommentIn: J Clin Oncol. 2023 Aug 20;41(24):4059-4060. - PMID 37348023
Wird geladen...
3
Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR) : A Randomized, Open-Label, Phase III Trial
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2023
von
Sonneveld, P.
|
Chanan-Khan, A.
|
Weisel, K.
| +16
CommentIn: J Clin Oncol. 2023 May 10;41(14):2668. - PMID 36940403
Wird geladen...
4
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX) : A Randomized, Open-Label, Phase III Trial
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2023
von
Dimopoulos, M.
|
Oriol, A.
|
Nahi, H.
| +19
Wird geladen...
5
Elotuzumab Plus Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma : Final Overall Survival Analysis From the Randomized Phase II ELOQUENT-3 Trial
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2023
von
Dimopoulos, M.
|
Dytfeld, D.
|
Grosicki, S.
| +13
CommentIn: J Clin Oncol. 2023 Mar 20;41(9):1788. - PMID 36626704
Wird geladen...
6
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2022
von
Garcés, J.
|
Cedena, M.
|
Puig, N.
| +25
CommentIn: J Clin Oncol. 2022 Sep 20;40(27):3099-3102. - PMID 35759726
Wird geladen...
7
Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple Myeloma
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2022
von
Costa, L.
|
Chhabra, S.
|
Medvedova, E.
| +14
Wird geladen...
8
Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting : CONSOLE
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2022
von
Hata, A.
|
Okamoto, I.
|
Inui, N.
| +10
Wird geladen...
9
Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia : Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2022
von
Kersten, M.
|
Amaador, K.
|
Minnema, M.
| +15
Wird geladen...
10
Phase I Study of Venetoclax Plus Daratumumab and Dexamethasone, With or Without Bortezomib, in Patients With Relapsed or Refractory Multiple Myeloma With and Without t(11;14)
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2021
von
Bahlis, N.
|
Baz, R.
|
Harrison, S.
| +12
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Filter aufheben
Thema: Research Support, Non-U.S. Gov't
Medienart
130
Aufsätze
79
E-Artikel
79
E-Ressourcen
51
Gedruckte Aufsätze
Zeitschriftentitel
Journal of clinical oncology : official journal...
Thema
130
7S5I7G3JQL
130
Dexamethasone
Research Support, Non-U.S. Gov't
129
Journal Article
60
Randomized Controlled Trial
59
Multicenter Study
40
Klinische Studie
30
69G8BD63PP
30
Bortezomib
28
Comparative Study
26
8N3DW7272P
26
Clinical Trial, Phase II
26
Cyclophosphamide
25
Cisplatin
25
Q20Q21Q62J
24
80168379AG
24
Doxorubicin
23
Clinical Trial, Phase III
21
5J49Q6B70F
21
Antiemetics
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
76
2000-
27
1900-1999
Erscheinungsjahr(e)
Von:
Bis:
Sprache
130
Englisch
Haven't found what you're looking for?
Wird geladen...